INFLUENZA

This is an early-stage study to test the safety and immune response of a new mRNA flu vaccine in healthy adults. Up to 50 participants, aged 18-49, will receive two doses of the experimental vaccine or one dose of a standard flu shot for comparison. The main goal is to see if the…

This study is testing a new type of flu vaccine called OVX836. It aims to provide broader protection against many different flu strains, not just the few selected each year. The trial involves 2,850 healthy adults aged 18-59 who will receive either the vaccine or a placebo shot. …

This study aims to check the safety of a new four-strain flu vaccine that includes an ingredient to boost the immune response. It will involve 80 healthy adults aged 65 and older. Researchers will closely monitor participants for any side effects or reactions for up to a year aft…

This study is testing the safety of a new flu vaccine designed for people aged 65 and older. It will enroll 80 healthy older adults to see how their bodies react to the shot. The main goal is to check for any side effects or safety issues over a year after vaccination.

This study aims to understand how a nasal spray flu vaccine triggers immune responses in the body. Researchers will give the vaccine to 60 healthy teenagers and collect blood and nasal samples to measure immune reactions. The goal is to learn how protection develops in both the b…

This early-stage study is testing different doses of an oral drug called TRX-100, given alongside standard flu care, in otherwise healthy adults with mild to moderate influenza. The main goals are to find a safe and effective dose and to see how the body absorbs and processes the…

This study is testing new, non-invasive devices that listen to body sounds to detect COVID-19, flu, and RSV. It involves 300 adults, both with and without symptoms, who are already getting standard screening tests at a military medical center. The goal is to see if these AI-power…

This study aims to find the most effective flu shot strategy for adults who recently received a kidney, heart, or liver transplant. Researchers are comparing different vaccine doses and schedules to see which provides the strongest immune protection. The goal is to better prevent…

This study is testing whether a new long-acting antiviral drug called CD388 can prevent the flu in adults and adolescents who are at higher risk of serious complications. Participants receive either the drug or a placebo as three small injections under the skin. The main goal is …

This study aims to find out which types of text message reminders are most effective at encouraging people to get their annual flu vaccine. It involves 100,000 patients who haven't yet received their shot. Researchers will test different message styles to see which one leads to t…

This study aims to understand how a baby's first encounter with the flu—whether through infection or vaccination—shapes their immune system's response to future flu exposures. Researchers will follow 1,500 mother-infant pairs from late pregnancy until the children are 3-4 years o…

This study aims to understand how COVID-19 and influenza symptoms affect people's daily lives and health over time. It will follow 999 adults in the US who test positive for either virus and report having symptoms. Participants will fill out surveys about their symptoms, work, an…

This study is exploring whether eating a diet high in fiber and prebiotic foods can change the bacteria in your gut and improve how well your body responds to the seasonal flu vaccine. Researchers are enrolling 31 healthy adults from MD Anderson Cancer Center to follow a specific…

This study aims to understand if the types of bacteria in your gut and what you eat can influence how well your body responds to the flu vaccine. Researchers are enrolling adults who are scheduled to get their annual flu shot. Participants will provide stool and blood samples and…

This study is testing a home smell test kit to see if it can reliably track how people's sense of smell recovers after a COVID-19 infection. Researchers will send smell cards to 1,000 participants, including people who lost their smell from COVID, healthy people, and those with o…